↓ Skip to main content

Microvesicles derived from human Wharton’s Jelly mesenchymal stromal cells ameliorate renal ischemia-reperfusion injury in rats by suppressing CX3CL1

Overview of attention for article published in Stem Cell Research & Therapy, March 2014
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
2 X users

Citations

dimensions_citation
229 Dimensions

Readers on

mendeley
140 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Microvesicles derived from human Wharton’s Jelly mesenchymal stromal cells ameliorate renal ischemia-reperfusion injury in rats by suppressing CX3CL1
Published in
Stem Cell Research & Therapy, March 2014
DOI 10.1186/scrt428
Pubmed ID
Authors

Xiangyu Zou, Guangyuan Zhang, Zhongliang Cheng, Deming Yin, Tao Du, Guanqun Ju, Shuai Miao, Guohua Liu, Mujun Lu, Yingjian Zhu

Abstract

Studies have demonstrated that mesenchymal stromal cells (MSCs) could reverse acute and chronic kidney injury by a paracrine or endocrine mechanism, and microvesicles (MVs) have been regarded as a crucial means of intercellular communication. In the current study, we focused on the therapeutic effects of human Wharton-Jelly MSCs derived microvesicles (hWJMSC-MVs) in renal ischemia-reperfusion injury and its potential mechanisms.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 140 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 2 1%
United States 1 <1%
Unknown 137 98%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 26 19%
Researcher 19 14%
Student > Master 18 13%
Student > Bachelor 17 12%
Student > Doctoral Student 7 5%
Other 21 15%
Unknown 32 23%
Readers by discipline Count As %
Medicine and Dentistry 29 21%
Biochemistry, Genetics and Molecular Biology 27 19%
Agricultural and Biological Sciences 13 9%
Engineering 7 5%
Neuroscience 5 4%
Other 13 9%
Unknown 46 33%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 May 2015.
All research outputs
#14,777,143
of 22,749,166 outputs
Outputs from Stem Cell Research & Therapy
#1,198
of 2,414 outputs
Outputs of similar age
#126,232
of 223,385 outputs
Outputs of similar age from Stem Cell Research & Therapy
#22
of 29 outputs
Altmetric has tracked 22,749,166 research outputs across all sources so far. This one is in the 32nd percentile – i.e., 32% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,414 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.0. This one is in the 44th percentile – i.e., 44% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 223,385 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 41st percentile – i.e., 41% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 29 others from the same source and published within six weeks on either side of this one. This one is in the 24th percentile – i.e., 24% of its contemporaries scored the same or lower than it.